Polymorphism of human cytochrome P450 enzymes and its clinical impact

SF Zhou, JP Liu, B Chowbay - Drug metabolism reviews, 2009 - Taylor & Francis
Pharmacogenetics is the study of how interindividual variations in the DNA sequence of
specific genes affect drug response. This article highlights current pharmacogenetic …

African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping

MC Campbell, SA Tishkoff - Annu. Rev. Genomics Hum. Genet., 2008 - annualreviews.org
Comparative studies of ethnically diverse human populations, particularly in Africa, are
important for reconstructing human evolutionary history and for understanding the genetic …

Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: Insights for applications in HIV therapy

A Owen, S Rannard - Advanced drug delivery reviews, 2016 - Elsevier
Advances in solid drug nanoparticle technologies have resulted in a number of long-acting
(LA) formulations with the potential for once monthly or longer administration. Such …

Clinical pharmacogenetics and potential application in personalized medicine

SF Zhou, Y Ming Di, E Chan, YM Du… - Current drug …, 2008 - ingentaconnect.com
The current 'fixed-dosage strategy'approach to medicine, means there is much inter-
individual variation in drug response. Pharmacogenetics is the study of how inter-individual …

[HTML][HTML] Insights into CYP2B6-mediated drug–drug interactions

WD Hedrich, HE Hassan, H Wang - Acta Pharmaceutica Sinica B, 2016 - Elsevier
Mounting evidence demonstrates that CYP2B6 plays a much larger role in human drug
metabolism than was previously believed. The discovery of multiple important substrates of …

HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms

RC Hartkoorn, W San Kwan, V Shallcross… - Pharmacogenetics …, 2010 - journals.lww.com
Objective OATP1B1 and OATP1B3 are major hepatic drug transporters whilst OATP1A2 is
mainly located in the brain but is also located in liver and several other organs. These …

Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants

ER Holzinger, B Grady, MD Ritchie… - Pharmacogenetics …, 2012 - journals.lww.com
Objectives Prior candidate gene studies have associated CYP2B6 516G→ T [rs3745274]
and 983T→ C [rs28399499] with increased plasma efavirenz exposure. We sought to …

Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent

J Yuan, S Guo, D Hall, AM Cammett, S Jayadev… - Aids, 2011 - journals.lww.com
Objective: Nevirapine is widely prescribed for HIV-1 infection. We characterized
relationships between nevirapine-associated cutaneous and hepatic adverse events and …

Efavirenz in the therapy of HIV infection

NY Rakhmanina, JN Van den Anker - Expert opinion on drug …, 2010 - Taylor & Francis
Importance of the field: The use of the first generation non-nucleoside reverse transcriptase
inhibitor efavirenz (EFV) as a component of first-line antiretroviral therapy has been …

Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6

SL Mo, YH Liu, W Duan, MQ Wei… - Current drug …, 2009 - ingentaconnect.com
CYP2B6 is mainly expressed in the liver that has been thought historically to play an
insignificant role in human drug metabolism. However, increased interest in this enzyme has …